Blar i Faculty of Medicine på tidsskrift "Medical Decision Making Policy & Practice"
Viser treff 1-1 av 1
-
Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia
(Journal article; Peer reviewed, 2021)Background. Metformin is a widely accepted first-line pharmacotherapy for patients with type 2 diabetes mellitus (T2DM). Treatment of T2DM with glibenclamide, saxagliptin, or one of the other second-line treatment agents ...